Status:
NOT_YET_RECRUITING
ADvanced ALzheimer Disease and Effects of Protologic and LAnguage Rehabilitation Tools in Nursing Home (ADALPA)
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Alzheimer Disease
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Background: During Alzheimer's disease when cognitive disorders become too severe, language and communication are no longer present and/or mobilizable, and as a consequence there is a frequent discon...
Eligibility Criteria
Inclusion
- subject aged ≥60 years
- living in nursing home
- presenting a neurocognitive disorder at an advanced stage
- MMSE \<10
- NPI ES : presence of apathy and/or indifference and/or aberrant motor behavior
- subject having received oral information and representative having received complete information on the organization of the research and not having objected to the participation of the patient and to the exploitation of data
- Subject or representative having consented to the fixation, reproduction and exploitation of the audiovisual recording.
Exclusion
- Delirium
- psychiatric disorder (diagnosed severe depressive disorder, diagnosed schizophrenia)
- Personnes benefiting from another non-pharmacological intervention or included in another research protocol
- subject deprived of liberty by a judicial or administrative decision
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06993285
Start Date
June 1 2025
End Date
December 1 2028
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CentralHNF
Vandœuvre-lès-Nancy, France, 54500